Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,656 | 592 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,212 | 93 | $0 (2024) |
| Novo Nordisk Inc | $944.90 | 54 | $0 (2024) |
| Astellas Pharma US Inc | $778.43 | 58 | $0 (2024) |
| Amgen Inc. | $754.31 | 54 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $682.74 | 22 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $529.84 | 42 | $0 (2023) |
| Allergan, Inc. | $434.95 | 40 | $0 (2020) |
| PFIZER INC. | $402.78 | 25 | $0 (2024) |
| Lilly USA, LLC | $368.47 | 32 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $349.76 | 21 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,265 | 80 | ABBVIE INC. ($249.84) |
| 2023 | $1,138 | 79 | ABBVIE INC. ($419.09) |
| 2022 | $890.13 | 53 | ABBVIE INC. ($195.52) |
| 2021 | $867.15 | 58 | AbbVie Inc. ($313.26) |
| 2020 | $414.59 | 31 | Allergan, Inc. ($193.83) |
| 2019 | $1,268 | 96 | Amgen Inc. ($188.93) |
| 2018 | $1,117 | 74 | Novo Nordisk Inc ($167.44) |
| 2017 | $1,696 | 121 | Boehringer Ingelheim Pharmaceuticals, Inc. ($196.42) |
All Payment Transactions
592 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: NEUROLOGY | ||||||
| 12/17/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: Biological | ||||||
| 12/16/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Neurology | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: Gastroenterology | ||||||
| 12/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $30.03 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $0.59 | General |
| Category: Diabetes | ||||||
| 12/02/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $9.64 | General |
| Category: Inflammation | ||||||
| 11/14/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Biological | ||||||
| 11/06/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Inflammation | ||||||
| 10/31/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $7.35 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/23/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Biological | ||||||
| 10/02/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Endocrinology | ||||||
| 10/01/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $5.11 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/26/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Obesity | ||||||
| 09/25/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Biological | ||||||
| 09/17/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $5.33 | General |
| Category: Bone Health | ||||||
| 09/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $26.17 | General |
| Category: Diabetes | ||||||
| 09/09/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $4.97 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Inflammation | ||||||
| 09/03/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: NEUROSCIENCE | ||||||
| 08/27/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/22/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Biological | ||||||
| 08/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,206 | 2,050 | $353,716 | $114,227 |
| 2022 | 14 | 1,243 | 2,112 | $335,852 | $104,816 |
| 2021 | 12 | 1,253 | 2,193 | $364,503 | $120,330 |
| 2020 | 20 | 1,567 | 2,455 | $352,337 | $106,973 |
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 375 | 776 | $208,667 | $63,342 | 30.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 208 | 208 | $60,763 | $25,590 | 42.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 46 | 157 | $26,473 | $6,726 | 25.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 95 | 115 | $22,080 | $6,434 | 29.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 279 | 401 | $7,863 | $3,354 | 42.7% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 33 | 80 | $8,664 | $2,054 | 23.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 25 | 25 | $3,900 | $1,895 | 48.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $4,158 | $1,745 | 42.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 34 | 34 | $2,414 | $982.60 | 40.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 46 | 97 | $4,656 | $930.24 | 20.0% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 21 | 110 | $1,870 | $491.70 | 26.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 12 | $1,440 | $468.71 | 32.5% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 21 | 24 | $768.00 | $212.54 | 27.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 346 | 705 | $189,535 | $55,202 | 29.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 163 | 163 | $44,626 | $19,134 | 42.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 47 | 164 | $30,200 | $10,056 | 33.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 125 | 160 | $30,676 | $9,186 | 29.9% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 42 | 124 | $14,592 | $3,005 | 20.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 35 | 36 | $5,108 | $2,464 | 48.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 313 | 501 | $7,515 | $1,483 | 19.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 51 | 54 | $2,538 | $1,461 | 57.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 17 | 18 | $2,124 | $760.39 | 35.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 41 | 79 | $3,792 | $759.08 | 20.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $2,684 | $512.66 | 19.1% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 16 | 16 | $768.00 | $335.76 | 43.7% |
About Dr. Kelly Nelson, MD
Dr. Kelly Nelson, MD is a Family Medicine healthcare provider based in Bridgeport, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1760435838.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kelly Nelson, MD has received a total of $8,656 in payments from pharmaceutical and medical device companies, with $1,265 received in 2024. These payments were reported across 592 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($8,656).
As a Medicare-enrolled provider, Nelson has provided services to 5,269 Medicare beneficiaries, totaling 8,810 services with total Medicare billing of $446,346. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Bridgeport, WV
- Active Since 05/18/2006
- Last Updated 01/13/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1760435838
Products in Payments
- UBRELVY (Drug) $548.38
- FARXIGA (Drug) $477.77
- LINZESS (Drug) $402.24
- Ozempic (Drug) $396.07
- VRAYLAR (Drug) $371.84
- TRADJENTA (Drug) $333.29
- Aimovig (Biological) $266.06
- Myrbetriq (Drug) $241.54
- Veozah (Drug) $225.18
- Prolia (Biological) $211.56
- Otezla (Drug) $201.07
- TRULICITY (Drug) $188.36
- INVOKANA (Drug) $175.61
- XARELTO (Drug) $174.15
- SYMBICORT (Drug) $169.53
- ENTRESTO (Drug) $167.36
- MYRBETRIQ (Drug) $164.58
- Rybelsus (Drug) $162.64
- ACCRUFER (Drug) $155.31
- VESICARE (Drug) $147.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Bridgeport
Dr. David Hess, M.d, M.D
Family Medicine — Payments: $28,349
George Homa, Do, DO
Family Medicine — Payments: $13,283
Frances Murray, Md, MD
Family Medicine — Payments: $12,525
Dr. Stephen Fryer, D.o, D.O
Family Medicine — Payments: $10,194
Dr. Jackson Maille, Md, MD
Family Medicine — Payments: $9,794
Brittanie West, Do, DO
Family Medicine — Payments: $7,927